BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27313697)

  • 1. Diffusion weighted imaging for the differential diagnosis of benign vs. malignant ovarian neoplasms.
    Meng XF; Zhu SC; Sun SJ; Guo JC; Wang X
    Oncol Lett; 2016 Jun; 11(6):3795-3802. PubMed ID: 27313697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
    Li B; Li Q; Chen C; Guan Y; Liu S
    Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors.
    Fan X; Zhang H; Meng S; Zhang J; Zhang C
    Int J Clin Exp Med; 2015; 8(11):19928-37. PubMed ID: 26884905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of imaging differential diagnosis of benign and malignant ovarian tumors.
    Wang WH; Zheng CB; Gao JN; Ren SS; Nie GY; Li ZQ
    Gland Surg; 2022 Feb; 11(2):330-340. PubMed ID: 35284306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis.
    Yuan X; Guo L; Du W; Mo F; Liu M
    Medicine (Baltimore); 2017 May; 96(19):e6659. PubMed ID: 28489739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of diffusion-weighted imaging for differentiating benign and malignant gallbladder lesions: A systematic review and meta-analysis.
    You MW; Yun SJ
    J Magn Reson Imaging; 2018 Nov; 48(5):1375-1388. PubMed ID: 29676860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging for differentiating between benign and malignant thoracic lymph nodes: a meta-analysis.
    Santos FS; Verma N; Watte G; Marchiori E; Mohammed TH; Medeiros TM; Hochhegger B
    Radiol Bras; 2021; 54(4):225-231. PubMed ID: 34393288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.
    Xu F; Liang Y; Guo W; Liang Z; Li L; Xiong Y; Ye G; Zeng X
    Front Oncol; 2021; 11():637681. PubMed ID: 34290974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of diffusion-weighted magnetic resonance imaging in differentiating human renal lesions (benignity or malignancy): a meta-analysis.
    Zhang H; Gan Q; Wu Y; Liu R; Liu X; Huang Z; Yuan F; Kuang M; Song B
    Abdom Radiol (NY); 2016 Oct; 41(10):1997-2010. PubMed ID: 27271218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation among Glioblastomas, Primary Cerebral Lymphomas, and Solitary Brain Metastases Using Diffusion-Weighted Imaging and Diffusion Tensor Imaging: A PRISMA-Compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2020 Feb; 11(3):477-483. PubMed ID: 31922391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI in differentiating malignant from benign thyroid nodules: a meta-analysis.
    Chen L; Xu J; Bao J; Huang X; Hu X; Xia Y; Wang J
    BMJ Open; 2016 Jan; 6(1):e008413. PubMed ID: 26733564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
    Du X; He Y; Lin W
    Front Neurol; 2022; 13():882334. PubMed ID: 35812103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Diffusion-Weighted Imaging in the Differential Diagnosis of Ovarian Lesions: A Meta-Analysis.
    Kim HJ; Lee SY; Shin YR; Park CS; Kim K
    PLoS One; 2016; 11(2):e0149465. PubMed ID: 26907919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of DWI with quantitative ADC values in ovarian tumors: a meta-analysis of diagnostic test performance.
    Pi S; Cao R; Qiang JW; Guo YH
    Acta Radiol; 2018 Nov; 59(11):1386-1394. PubMed ID: 29463093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Assessment of Different Neoplasias in the Adnexa in the Differential Diagnosis of Malignant Ovarian Tumor and Benign Ovarian Tumor: A Meta-analysis.
    Yue X; Zhong L; Wang Y; Zhang C; Chen X; Wang S; Hu J; Hu J; Wang C; Liu X
    Ultrasound Med Biol; 2022 May; 48(5):730-742. PubMed ID: 35272892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of diffusion-weighted imaging in the differential diagnosis of renal lesions.
    Li Y; Wang Y; Qin J; Wu J; Dai X; Xu J
    Clin Imaging; 2018; 52():264-272. PubMed ID: 30172176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the utility of quantitative diffusion-weighted MR imaging as a tool in differentiation between malignant and benign thyroid nodules.
    Wu LM; Chen XX; Li YL; Hua J; Chen J; Hu J; Xu JR
    Acad Radiol; 2014 Mar; 21(3):355-63. PubMed ID: 24332602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors.
    Qiao JJ; Yu J; Yu Z; Li N; Song C; Li M
    PLoS One; 2015; 10(3):e0118872. PubMed ID: 25764442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Superb Microvascular Imaging in Differentiating Benign and Malignant Breast Tumors: A Systematic Review and Meta-Analysis.
    Feng J; Lu J; Jin C; Chen Y; Chen S; Guo G; Gong X
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.